ALMKT:EPA
Mauna Kea Technologies SA
€0.091
arrow_downward
-0.33%(-0.00030) 1D
Nob 17, 4:14:06 PM GMT+1 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ALMKT...
Buksan
€0.09
Mataas
€0.09
Mababa
€0.09
Mkt. cap
17.99M
Avg. na dami
478.35K
Dami
252.46K
P/E ratio
0.77
Mataas nang 52-wk
€0.23
Mababa nang 52-wk
€0.07
EPS
€0.12
Mga natitirang share
195.26M
Bilang ng mga empleyado
56
Buksan
€0.09
Mataas
€0.09
Mababa
€0.09
Mkt. cap
17.99M
Avg. na dami
478.35K
Dami
252.46K
P/E ratio
0.77
Mataas nang 52-wk
€0.23
Mababa nang 52-wk
€0.07
EPS
€0.12
Mga natitirang share
195.26M
Bilang ng mga empleyado
56
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TradingView
·
2 oras ang nakalipas
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
1 oras ang nakalipas
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
54 minuto ang nakalipas
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
Traders Union
·
1 oras ang nakalipas
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Tungkol sa Mauna Kea Technologies SA
CEOSacha Loiseau
Mga Empleyado56
Itinatag2000
Headquarters-
SektorHealth Care
Industriya-
Websitemaunakeatech.com